Advancing Our Clinical Perspectives in Haematology: What Is Your Approach? - European Medical Journal
×

Browse

Advancing Our Clinical Perspectives in Haematology: What Is Your Approach?

| Download as | PDF
Chairpeople:
Sarah Jarvis1
Speakers:
Gunnar Birgegård,2 Tamara Lado Cives,3 Sélim Aractingi,4 Chiaki Nakaseko,5 Claire Harrison,6 Melania Moreno Vega,7 Jean‑Jacques Kiladjian,8 Salah Alimam,9 Manuel Martinez‑Sellés10
Disclosure:

Sarah Jarvis has no conflicts of interests to disclose. Gunnar Birgegård has received speaker’s fees/honoraria from Shire and Vifor Pharma. Tamara Lado Cives has no conflicts of interest to disclose.  Sélim Aractingi has received research support from Leo Pharma, speaker’s fees/honoraria from Shire, Novartis, and AbbVie and has served on advisory boards for Shire and Novartis. Chiaki Nakaseko has  received research support from Bristol‑Myers Squibb, Pfizer, Kyowa‑Hakko Kirin, Takeda, Chugai, Otsuka, Shionogi, and Asahikasei‑Pharm and speaker’s fees/honoraria from Pfizer, Celgene, Bristol‑Myers Squibb,  and Shire. Claire Harrison has received research support from Novartis, speaker’s fees/honoraria from Novartis, Shire, CTI, Baxalta, Gilead, and Incyte and has served on advisory boards for CTI, Baxalta, and Novartis. Melania Moreno Vega has no conflicts of interests to disclose. Jean‑Jacques Kiladjian has received research support from Novartis, speaker’s fees/honoraria from Novartis, Shire, and AOP Orphan and has served on advisory boards for Novartis, Shire, and AOP Orphan. Samah Alimam has no conflicts of  interests to disclose. Manuel Martinez‑Sellés has received research support from Servier, Novartis, and  Pfizer, speaker’s fees/honoraria from Servier, Shire, Novartis, and Pfizer and has served on advisory boards for Shire.

Acknowledgements:

The 11th New Horizons in Haematology conference was initiated, organised, and  funded by Shire. Medical writing assistance was funded by Shire. The views and opinions expressed are those of the authors as expressed during the conference and not necessarily those of Shire.

Citation
EMJ Hematol. ;4[Suppl 9]:2-9.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Meeting Summary

The 11th New Horizons in Haematology (NHH11) conference was moderated by Dr Sarah Jarvis, healthcare reporter and television presenter, and was delivered in the format of a live, interactive, online meeting. Prof Gunnar Birgegård opened the conference with a presentation on the evolution of essential thrombocythaemia (ET) disease, Prof Sélim Aractingi described the incidence of skin lesions in myeloproliferative neoplasms (MPN), Prof Claire Harrison discussed key aspects in women’s health when managing ET including pregnancy, Prof Jean‑Jacques Kiladjian covered the management of elderly patients with ET, and Dr Manuel Martínez‑Sellés concluded the meeting by emphasising the importance of identifying and managing cardiovascular (CV) risk factors in ET. Dr Tamara Lado Cives, Prof Chiaki Nakaseko, Dr Melania Moreno Vega, and Dr Samah Alimam each shared a case study after the main presentations.

Receive our free quarterly newsletters and your choice of journal publication alerts, straight to your inbox.

Join our mailing list

Please view the full content in the PDF above.